When the San Antonio Spurs selected Victor Wembanyama with the No. 1 pick in the 2023 NBA Draft, he was viewed as a ...
Victor Wembanyama's second NBA season was cut short due to a blood clot in his shoulder. Let's contextualize just how ...
Victor Wembanyama is expected to miss the remainder of the 2025 regular season with a blood clot in his right shoulder. The 7-foot-3 Spurs center, who was the clear favorite to win Defensive ...
French star and reigning NBA Rookie of the Year Victor Wembanyama is expected to miss the rest of the season with a blood clot in his right shoulder, the San Antonio Spurs announced Thursday.
NBA fans were dealt some terrifying news when they learned Victor Wembanyama will unfortunately miss the remainder of the season. The San Antonio Spurs star big man was diagnosed with a deep vein ...
The San Antonio Spurs announced Thursday that star center Victor Wembanyama will miss the rest of the season because of deep vein thrombosis in his right shoulder. Losing the second-year ...
Victor Wembanyama, the San Antonio Spurs' 7-foot 3-inch phenom, was sidelined after doctors discovered a dangerous blood clot ...
OK, let’s get this part out of the way first: The viral $10,000 bet allegedly placed on Victor Wembanyama to win Defensive Player of the Year an hour before ESPN’s Shams Charania reported the ...
NBA 2K25 Season 5 is headlined by San Antonio Spurs' Center Victor Wembanyama. Drafted first overall last year, Wemby made an ...
Victor Wembanyama’s net worth in 2025 is an estimated $10 million. Wembanyama is the star center and Rookie of the Year for the San Antonio Spurs. However, his second season came to an abrupt ...
NBA All-Star Victor Wembanyama is expected to miss the rest of the season after being diagnosed with deep vein thrombosis in his right shoulder, the San Antonio Spurs announced Thursday.
On Thursday, the San Antonio Spurs announced that Victor Wembanyama—the 7-foot-3, 21-year-old center set to be the NBA’s next generational superstar—would miss the remainder of the NBA season.